FDA.reportPublic FDA data

10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]

RxCUI
1726984
RxNorm name
10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]
Display name
10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]
Full name
10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125561Kanumasebelipase alfa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
83a77b9d-42f0-4645-8420-786285da732610 ML sebelipase alfa 2 MG/ML Injection [Kanuma]SBD11These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous use Initial U.S. Approval: 201520250721
83a77b9d-42f0-4645-8420-786285da7326Kanuma 20 MG in 10 ML InjectionPSN11These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous use Initial U.S. Approval: 201520250721
83a77b9d-42f0-4645-8420-786285da732610 ML Kanuma 2 MG/ML InjectionSY11These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous use Initial U.S. Approval: 201520250721
83a77b9d-42f0-4645-8420-786285da7326Kanuma 20 MG per 10 ML InjectionSY11These highlights do not include all the information needed to use KANUMA safely and effectively. See full prescribing information for KANUMA. KANUMA (sebelipase alfa) injection, for intravenous use Initial U.S. Approval: 201520250721